Answers are grounded in this paper and cite their sources.
Observational study finds improved clinical outcomes and absenteeism in type 2 diabetes, suggesting economic benefits for employers.
In this population, CGM was associated with improvements in clinical outcomes and absenteeism, although the economic implications require further evaluation. BMI and absenteeism were statistically significantly improved among persistent patients, compared with those of the nonpersistent cohort. Employers could benefit from broader coverage of CGM in this population.
No takes yet. Share an insight, caveat, or question.
Shepherd et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: